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Title: Variation in Plasma Prostaglandin Bi Level in Mouse During Infection With 
Trichinella spiralis and Trichinella pseudospiralis. 
Polymorphonuclear leukocytes infiltrate tissues in response to an inflammatory 
stimulus such as endotoxin or parasite products. Previous studies have shown an 
extensive cellular infilteration about the parasitized skeletal muscle of mouse infected 
with the nematode, Trichinella spiralis. Infection of the host with Trichinella 
pseudospiralis, on the other hand, is associated with a dramatic suppression of 
inflammatory cellular response. 
Prostaglandin Bi is a product of arachidonic acid metabolism and is synthesized 
by variety of cell types. Prostaglandins of the E series have been generally known to 
suppress inflammatory responses. 
In the present study, I have investigated the possible relation between plasma 
prostaglandin Bi levels and host cellular response in infected mice. Concentrations of 
prostaglandin Bi in mice plasma were measured at 5, 11, and 21 days after infection with 
f 
larvae of either nematode species by enzyme immunoassay. 
There were noticeable elevations in the concentrations of prostaglanding Bi in 
samples of mice infected with Trichinella pseudospiralis compared to controls. 
Conversely, decreased levels of prostaglandin Bi were observed in samples from the mice 
infected with Trichinella spiralis. 
These results suggest that the differences observed in the host inflammatory 
response to infection with Trichinella spiralis versus Trichinella pseudospiralis might be 
associated with recognized properties of prostaglandin Bi· In this connection, I have 
suggested three possible mechanisms by which the differences of inflammatory response 
in relation to PGEi production may be explained. 
VARIATION IN PLASMA PROSTAGLANDIN Bi LEVEL 
IN MOUSE DURING INFECTION WITH 
TRICHINELLA SPIRALIS AND TRICHINELLA PSEUDOSPIRALIS 
by 
ZAHRA MEHDIZADEHKASHI 
A thesis submitted in partial fulfillment of the requirements for the degree of 
MASTER OF SCIENCE 
in 
BIOLOGY 
Portland State Univeristy 
1995 
ACKNOWLEDGEMENTS 
I would like to express my gratitude to Dr. David Clark for all the assistance, 
information, technical advice, and encouragement he provided me throughout the years 
of my graduate studies. 
Also, I wish to thank Dr. Douglas Dooley, Director of the Research and 
Development Lab and Mrs. Maria Ferraro, Section Head of the Tissue Typing Lab in 
American Red Cross for their generosity with reagents and equipment which made this 
project possible. 
I am very much obliged to the members of the thesis committee: Drs. Deborah 
Duffield, Lester Newman, and Dirk Iwata-Reuyl for their time and review of this 
document. 
I am grateful beyond measure to my best ever friend, Mark Soloos, whose 
support and help has been a driving force for me during the pursuit of my Master's 
Degree. 
I owe a special debt of gratitude to my mother, Iran Alizadeh, from whose 
encouragement and support I have earned all my education. 
Finally, I am deeply indebted to my daughter, Ghazal Sharifi and my husband, 
Hadi Sharifi for their patience and understanding without which this project would never 
have been accomplished. 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . ......... 111 
LIST OF TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v 
LIST OF FIGURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Vl 
INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
REVIEW OF LITERATURE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 
MATERIALS AND METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 
Establishment of Infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 
Blood Collection and Processing . . . . . . . . . . . . . . . . . . . . . . . . . . 14 
Plasma Purification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 
Prostaglandin Bi Kit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16 
Preassay Preparation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 
Plate Set Up . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 
24 
REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 
APPENDIX A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 
APPENDIX B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44 
APPENDIX C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45 
LIST OF TABLES 
TABLE PAGE 
1 Synthesis of Prostaglandins and Thromboxanes by Cells 
Involved in inflammatory responses . . . . . . . . . . . . . . . . . . . . 7 
2 Prostaglandin Bi - Monoclonal Enzyme Immunoassay 
Kit Specificity. . . . . . . . . . . . . . . .................. 17 
3 Test Plate Format . . . . . . . . . . . . . . . . . . . . . . . . ..... 23 
4 Presentation of raw data; the Location of each well corresponds 
to that of plate format presented in Table 3. . . . . . . . . . . . . 26 
5 Corrected Maximum Binding, and % Sample and Standard 
Bound/Maximum Bound (% B/B0) • • • • ••••••••••••••• 27 
6 PGEi concentration of known standards (shaded) and unknown 
various groups of mice (unshaded) . . . . . . . . . . . . . . . . . 30 
LIST OF FIGURES 
FIGURE PAGE 
1 Prostaglandin Nomenclature . . . . . . . . . . . . . . . . . . . . . . . . . 8 
2 The Synthesis of Prostaglandins and Thromboxanes 
(adapted from Davies and Macintyre, 1992) . . . . . . . . . . . . . 10 
3 Reaction catalyzed by acetylcholinesterase ................. 19 
4 Schematic of Enzyme Immunoassay . . . . . . . . . . . . . . . . . . . . . . 21 
5 Standard curve for PG:Ei using the Prostaglandin Bi monoclonal 
enzyme immunoassay kit . . . . . . . . . . . . . . . . . . . . . . . . . . . 28 
6 Comparison of PG:Ei variation in the Mouse Infected with 
Trichinella spiralis versus Trichinella pseudospiralis at 
various intervals postinf ection . . . . . . . . . . . . . . . . . . . . . 31 
INTRODUCTION 
Trichinella spiralis is a parasite nematode which occurs within the phylum 
Nematoda, class Amphasmidia, order Trichurata, family Trichinellidae (Schmidt and 
Roberts 1989). Trichinella spiralis was described by Owen in 1835 and it was 
considered the only species in the genus Trichinella (Kramar et al., 1981). However, 
within the last 20 years, researchers have employed a variety of methods for the study 
and description of the systematics of Trichinella. These include geographic distribution, 
nurse cell development, reproductive capacity index (RCI), resistance to freezing, 
alloenzyme markers and host pathogenicity (Pozio et al., 1992). Together, these studies 
demonstrate that the genus Trichinella is composed of eight distinct gene pools, termed 
Tl - T8 by La Rosa et al. in 1992. Five of these genetic groups were proposed as 
species: Trichinella spiralis sensus stricto (Tl) described by Owen in 1835; Trichinella 
pseudospiralis (/'4) described by Garkavi in 1972; Trichinella nativa (12), Trichinella 
nelsoni (/'7), Trichinella britovi n. sp. (/'3) all described by Britov and Boev in 1972 
(Pozio et al., 1992). Three other cluster groups, named T5, T6, and T8 have been 
recognized in the genus Trichinella, but at present their taxonomic level is uncertain. 
Trichinella pseudospiralis is differentiated from Trichinella spiralis by differences 
in morphology, alloenzyme characteristics, host spectrum, the absence of a capsule or 
nurse cell surrounding the skeletal muscle larva (Kramar et al., 1981). Additionally, an 
interesting property of Trichinella pseudospiralis is the apparent ability of the parasite 
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to down-modulate inflammatory responses directed at larval forms in skeletal muscles 
(Neva and Brown, 1994). While there is an extensive cellular infiltration of 
polymorphonuclear neutrophils about the parasitized skeletal muscle of mouse infected 
by Trichinella spiralis, an infection of the mouse with Trichinella pseudospiralis is not 
accompanied by strong host inflammatory cellular response (Stewart and Larsen, 1989). 
Among the supporting evidence is a study undertaken by Larsen et al. in 1989 on 
infection of Chinese hamster ( Cricetulus grigeus) with Trichinella pseudospiralis. 
Chinese hamster has a strong innate resistance to the muscle phase of Trichinella spiralis. 
This is because the pre-encapsulated larvae in the skeletal muscles of the Chinese hamster 
are encountered by intense influx of inflammatory cells which surround and rapidly 
destroy the majority of worms (Ritterson, 1959). On the other hand, a much greater 
inf ectivity for the Trichinella pseudospiralis is seen in Chinese hamster. This is because 
the infection with Trichinella pseudospiralis is accompanied by markedly low level of 
myositis and cellular infiltration (Stewart et al., 1982). Larson et al. demonstrated that 
the concurrent infection of Chinese hamster with these two species of parasite led to an 
increase in infectivity of Trichinella spiralis. They suggested that during concurrent 
infection, suppression of myositis and cellular infiltration by Trichinella pseudospiralis 
lessens the destruction of Trichinella spiralis larvae by the host inflammatory response 
(Larsen et al., 1991). 
Furthermore, Stewart and his co-workers in 1989 showed that modulation of host 
defenses by Trichinella pseudospiralis includes suppression of host inflammatory 
response and an increase in pulmonary natural killer cell activity. During the course of 
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this study, they attempted to eliminate natural killer cell activity in vivo by injection of 
antibody against a natural killer cell surface antigen (asialo GM1). The outcome was a 
rapid and high mortality among mice infected with Trichinella pseudospiralis, but not 
among mice infected with Trichinella spiralis (Stewart et al., 1989). 
Finally, Prulhiere in 1994 compared neutrophil migration in the mouse in 
response to individual infections with each of the two species of Trichinella. He showed 
that the muscle phase of infection in the mouse by Trichinella spiralis was accompanied 
by myositis and a pronounced neutrophil infiltration, whereas there were none to few 
neutrophils present in the Trichinella pseudospiralis infected muscle fibers (Prulhiere, 
1994). 
The purpose of my study was to determine whether the variation in inflammatory 
cell infiltration in the early stages of skeletal muscle infection induced by Trichinella 
spiralis and Trichinella pseudospiralis in the mouse was associated with the anti-
inflammatory role of prostaglandin Bi. To investigate this we measured and compared 
the Prostaglandin Bi level of mice plasma infected individually with each of the two 
species. This included the quantitation at three different time periods during the first 21 
days postinfection. We concluded that the prostaglandin Bi (PGEi) plasma level was 
increased in hosts infected with Trichinella pseudospiralis compared with hosts infected 
with Trichinella spiralis. 
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REVIEW OF LITERATURE 
The emigration of inflammatory cells from the blood into the tissues represents 
one of the most important components of the inflammatory response. Collectively, 
inflammation is a defensive response to invasion of the host by foreign material, often 
microbial in nature although mechanical trauma, toxins, and neoplasia also may lead to 
inflammatory responses. Inflammation involves vasodilation, increased vascular 
permeability, and cellular infiltration (neutrophils and mononuclear cells). 
The local accumulation of leukocytes is commonly preceded by the binding of 
circulating leukocytes to the vascular endothelium, followed by diapedesis of the 
phagocytic cells through spaces between the endothelium (Snyderman and Uhing, 1992). 
The category of phagocytic inflammatory cells includes neutrophils, eosinophils 
and mononuclear phagocytic series. Macrophages are central components of the 
mononuclear phagocytic system. The main role of tissue macrophages is to recruit more 
phagocytic cells to the site of infection by releasing a battery of cytokines. 
The cytokines which are produced by monocytes and macrophages are called 
monokines. Monokines include interleukin-I, interleukin-6, interleukin-8, interleukin-12, 
and tumor necrosis factor-a and are synthesized upon recognition of microbial 
constituents by macrophages. Some of these monokines belong to a group of proteins 
termed chemokines. Chemokines are synthesized by macrophages, endothelial cells, the 
keratinocytes, the fibroblasts and smooth cells of connective tissue. The chemokines 
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serve as chemoattractants for phagocytic cells, recruiting macrophages and neutrophils 
from the circulation to the site of infection. Chemokines fall into two broad subclasses, 
a and {3. The a chemokines encourage migration of neutrophils and the {3 chemokines 
promote migration of monocytes. While classical chemotactic agonists such as the 
cleavage product of the fifth component of complement (C5a), N-Formyl-methionyl-
leucyl-phenylalanine (FMLP), and Leukotriene B4 (LTB4) attract different types of 
granulocytes, IL-8, an (Y_ chemokine, appears to be unusually selective for neutrophils 
(Janeway and Travers, 1994). 
Additionally, leukocytes migrate from the circulation to accumulate at sites of 
inflammation in response to inflammatory mediators. These chemical substances modify 
blood flow, increase vascular permeability, add to adherence of circulating leukocytes 
to vascular endothelium, encourage migration of leukocytes into tissues, and stimulate 
leukocytes to destroy the invading agent (Goldyne and Stobo, 1981). Some of the well 
characterized mediators of inflammation include: histamine, a vasoactive amine stored 
performed in cytoplasmic granules of mast cells and basophils; serotonin, a vasoactive 
amine found in the blood platelets of all mammalians and in most cells of rodents and 
cattle; and prostaglandin, a group of fatty acids produced by most mammalian cells 
(Walker and Wilson, 1980). 
The most obvious role for prostaglandins in the immune response is 
proinflammatory activity. The fact that inhibitors of prostaglandin synthesis are 
nonsteroid anti-inflammatory drugs, with aspirin being a prototype, is the best evidence 
for predominantly proinflammatory function of prostaglandins. The action of these anti-
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inflammatory drugs is based on the inhibition of cyclo-oxygenase, the enzyme which 
catalyzes the initial conversion of arachidonic acid into the precursors of the various 
prostaglandins (Goodwin and Webb, 1980). A less well recognized function of 
prostaglandins is the negative regulation of hum oral and cellular immunity, which would 
be considered an anti-inflammatory function. Due to their dual activity, prostaglandins 
are referred to as "regulators" or "modulators" of inflammation (Zurier, 1990). 
Endogenous sources of arachidonic acid that give rise to prostaglandins and other 
eicosanoids (20 carbon fatty acids) are contained in the membrane phospholipids of a 
variety of resting mammalian cells. The synthesis of prostaglandins starts when cells are 
stimulated by antigenic stimuli (for example, endotoxins or parasite products) to release 
arachidonic acid. Table 1 summarizes the major sources of prostaglandins in acute 
inflammation (Davies and Macintyre, 1992). 
Prostaglandins (PGs), referred to as prostanoids, are oxygenation products of 
arachidonic acid, a long-chain derivative of linoleic acid. The term "prostaglandin" 
resulted from the erroneous assumption that the prostate gland was a primary source of 
this activity. It is only in the last 20 years that the chemical structure and the biological 
activity of many of the members of this family have been established (Higgs and Vane, 
1983). Prostaglandins are a group of polyunsaturated, oxygenated 20 carbon atom fatty 
acids which contain a cyclopentane ring between carbon 8 and carbon 12. 
Prostaglandins are named in alphabetical order and currently nine units (shown 
in Figure 1) are recognized (PGA through PGI). The first prostaglandins identified were 
named PGE and PGF because of their respective partitioning into ether and phosphate 
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Table 1. Synthesis of prostaglandins and thromboxanes by cells involved in inflammatory 
responses (adapted from Davies and Macintyre, 1992) 
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Figure 1. Prostaglandin nomenclature: (a) basic structure common to all PGs, (b) groups are given letter 
designations according to the substitutions on the pentane ringe and in the case of PGG on C15'· PGFa and 
PFG{3 differ in the orientation of the -OH group on C9, (c) series are given numerical subscript following group 
name, which corresponds to number of double bonds in side chains (adapted from Goldyne and Stobo, 1981). 
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buffer solvents, "E" representing ether and "F" representing phosphate (Fosfat in 
Swedish). Prostaglandins are further characterized by the number of double bonds in the 
molecule. The number of double bonds are indicated by a suffix; for example, PGEi has 
two double bonds (Goldyne and Stobo, 1981). 
Prostaglandins are produced when arachidonic acid is metabolized by the enzyme 
cyclo-oxygenase, also known as prostaglandin G/H synthase. The enzyme catalyzes 
oxygenation of carbon 11 of arachidonic acid, with the formation of a cyclic 
endoperoxide in which an oxygen molecule attaches carbon 9 to carbon 11. 
Incorporation of a second oxygen molecule at carbon 15 produces PGG2• Subsequently 
PGH2 is formed as a result of peroxidase activity (Figure 2) (Davies and Macintyre, 
1992). 
Prostaglandins of the E series (PGE) are known to inhibit a number of functions 
of the immune system (Chouaib et al., 1985). Kloeze in 1967 reported that PGE1 
inhibits platelet aggregation. This led to the notion that the arachidonic acid metabolites 
may have anti-inflammatory activity (Zurier, 1990). Other investigators then showed in 
various in vitro and in vivo assay systems that PGEi and PGEi could serve as inhibitors 
of inflammatory response. 
Zurier et al. in 1973 reported that PGEi and PGEi suppressed acute carrageenan-
induced inflammation and chronic joint inflammation characteristic of adjuvant disease 
in the rat (Zurier et al., 1973). Thompson and her co-workers in 1984 studied the role 
of PGEi in the regulation of human B cell proliferation in response to Staphylococcus 
(l66l 'a.iA!upvw 













aureus. They found that PGEz suppressed B cell DNA synthesis and proliferation 
stimulated by Staphylococcus aureus (Thompson et al., 1984). 
Rivkin et al. in 1975 showed that PGEi and PGA1 inhibited neutrophil chemotaxis 
induced by Escherichia coli culture filtrate (Rivkin et al., 1975). Pantone and his co-
workers in 1980 investigated the effect of PGEi on vasopermeability induced by 
vasoactive mediators such as histamine and serotonin which initiate inflammatory 
reactions. They concluded that PGE1 or its stable derivative, 15-(S)-15-methyl-
prostaglandin E1, markedly reduce the increase in vasopermeability induced by these 
chemicals (Pantone et al., 1980). 
Rossi and O'Flaherty in 1989 showed that PGEi and PGD2 inhibited 
polymorphonuclear (PMN) neutrophil degranulation responses to infection-induced 
leukotriene B4 (leukotriene B4 is produced by cells of myelomonocytic lineage and is a 
potent proinflammatory mediator which induces chemotaxis, chemokinesis, aggregation, 
and degranulation of PMN leukocytes, as well as PMN adherence to endothelial cells. 
It is also a chemoattractant for monocytes and amplifies inflammatory reactions) (Rossi 
and O'Flaherty, 1989). 
Raud and his associates in 1988 conducted an experiment in hamsters to 
characterize the influence of PGEi and indomethacin (a nonsteroidal anti-inflammatory 
drug which inhibits cyclooxygenase) on microcirculatory changes during inflammation 
induced by antigen challenge. They revealed that indomethacin reduced antigen-induced 
vasodilation while potentiating plasma leakage, leukocyte accumulation and histamine 
release of the mast cells in cheek pouches of immunized hamsters. Then they observed 
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that the topical application of PGEi reversed the indomethacin-induced inflammatory 
responses to antigen. Prostaglandin Bi induced a marked vasodilation and effectively 
reversed the enhanced number of emigrated leukocytes after indomethacin treatment 
(Raud et al., 1988). 
All of the above studies support the concept that several prostaglandins, mainly 
prostaglandins of the E series, predominantly inhibit acute inflammation. Further 
investigations are necessary to unravel the functions of eicosanoid mediators in the 
inflammatory response. I have taken a step toward these directions by measuring and 
comparing the plasma PGEi level in the mouse infected with Trichinella pseudospiralis 
or Trichinella spiralis. 
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MATERIALS AND METHODS 
Animals and Parasites 
Six-to-eight-week-old MRL ++mice were used as experimental hosts and controls. 
Animals were maintained on a 12-hour light-dark photoperiod and provided water and 
commercially prepared food ad libitum. The care of all animals was in accordance with 
the guidelines set forth by the National Institute of Health provided in the "Guide for the 
Care and Use of Laboratory Animals". 
The Indiana bore strain of Trichinella spiralis isolated by Kazacoskr (Kazacoskr 
et al., 1986) was obtained from Dr. Green, University of Missouri, Columbia. 
Trichinella pseudospiralis was obtained from H. Ray Gambel, USDA, Beltsville, Md. 
Both species of parasites were maintained through passage in rats and mice at Portland 
State University. 
Establishment of Infection 
Infective larvae were isolated from the carcasses of older MRL + + mice infected 
with Trichinella spiralis or Trichinella pseudospiralis. Mice were killed by cervical 
dislocation and skeletal muscle containing the infective larvae were recovered. Small 
pieces of muscle tissue containing approximately 150-200 infective larvae were selected. 
The presence of larvae in each tissue portion was confirmed by examining it under a 
dissecting microscope. 
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To assure rapid consumption of the infected tissue, the mice were restricted from 
food for approximately 15-20 hours prior to infection. A panel of five to six mice, held 
individually in a cage without litter, were fed with Trichinella spiralis or Trichinella 
pseudospiralis infected tissue that was moistened with water. During the feeding period, 
the mice were periodically observed to ensure that the tissue pieces were moist and 
available to each animal. When the meat pieces were consumed, the mice would be 
returned to the diurnal rhythm of light with food and water ad libitum. 
Additionally, five to six mice were left uninfected to serve as control for 
provision of in vivo base line concentrations of prostaglandin Bi. 
Blood Collection and Processin2 
Animals were anesthetized with Metophane approximately 5-10 minutes before 
blood collection (Metophane was obtained from Oregon Health Sciences University, 
Animal Care Center). Fresh blood was collected by cardiac puncture from 5-6 mice of 
each infection on 5, 11, and 21 days postinfection ( dpi). The control specimen was 
obtained by bleeding 5-6 normal, uninfected mice and pooling the collection into one 
control specimen. Once drawn into a sterile syringe, the blood was immediately injected 
into 3 mL vacutainer tubes containing the anticoagulant ethylenediaminetetraacetic acid 
(EDTA). 
Following blood collection each mouse was evaluated for infection. A midline 
laparotomy was performed and several sections of the host intestine and diaphragm were 
removed for microscopic evaluation on the stage of infection. The infection of the host 
was assessed by visually observing the adult worms of each species in the host intestine 
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at day 5 postinfection. Additionally, I examined diaphragms from infected mice 
which appeared normal at this time, suggesting that the larvae had not yet reached the 
diaphragm in sufficient number to be easily seen. 
Upon examination of the host diaphragm at day 11 postinfection, we observed the 
presence of a few larvae. Therefore, an early stage of muscle infection was confirmed 
in the host infected with each species. 
Finally, I found a great number of larvae in the host diaphragm at day 21 
postinfection. This was indicative of a heavy infection of each species in the host. 
The blood samples were centrifuged at 1500 x g for 13 minutes at room 
temperature. Plasma was removed and delivered to sterile polypropylene tubes. Each 
sample and control tube was composed of a pool of 2 - 2.5 mL plasma from five to six 
mice. All plasma samples were stored at -80°C and assayed within five weeks. 
Plasma Purification 
Prior to assaying for PGEi, all plasma samples were obtained from -80°C, thawed 
at room temperature and purified. The purpose of purification was to minimize the 
interferences resulting from many substances contained in the plasma, especially active 
proteins. 
Plasma samples were also concentrated 10 fold by purifying a larger volume of 
the sample and reconstituting in a small amount of buffer. The purpose of concentration 
was to bring the expected level of PGEi content of samples within the readable range of 
the standard curve. A 2 mL aliquot of each plasma sample was placed into a clean test 
tube. Methanol at 8 mL was added to the samples. The samples were vortexed and 
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allowed to stand at 4 °C for five minutes. The samples were then centrifuged at 3000 x 
g for 10 minutes at room temperature to remove the precipitated proteins. 
The supernatant was transferred into a clean container and 32 mL of 0.1 M 
phosphate buffer, pH 4, was added and the container was vortexed briefly. Sep-pak C18 
{C18) cartridges (Water Associates; Milford, MA) were assembled by removing the 
plunger from a IO-milliliter sterile syringe and placing the long end of a C18 cartridge 
on the luer tip of the syringe barrel. The C18 cartridges were then activated one at a time 
by rinsing with 5 mL methanol (see Appendix A) and then with 5 mL ultrapure water 
(see Appendix B). 
Each sample was passed through an activated C18 cartridge. The cartridge was 
rinsed with 5 mL ultrapure water followed by 5 mL of HPLC grade hexane. Both 
washes were discarded and expected PGEi was eluted to a clean test tube with 5 mL 
ethyl acetate containing 1 % methanol. The ethyl acetate was evaporated to dryness under 
a stream of dry nitrogen. Enzyme Immunoassay (EIA) buffer at 200 mL was added and 
the tube was vortexed. The sample was then ready for quantitation assay. 
Prostaelandin Ei Kit 
A prostaglandin Bi - Monoclonal Enzyme Immunoassay Kit was purchased from 
Cayman Chemical Company; Ann Arbor, MI and stored at -20°C until used. The kit 
is validated for use with urine, culture media and plasma samples, and has an assay 
sensitivity of 7. 8 pg/mL. Table 2 summarizes the specificity of the kit for PGEi 
compared with other prostaglandins (PGJ. 
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Table 2 Prostaglandin Bi - Monoclonal Enzyme Immunoassay Kit Specificity 




6-Keto PG F1" 1% 
PGA1 < 0.01 % 
PGA3 < 0.01 % 
PGB1 < 0.01% 
PGBi < 0.01 % 
PGD2 < 0.01% 
15-Keto PGEi < 0.01% 
13, 14 - Dihydro -15-Keto PGF2a < 0.01 % 
13, 14 - Dihydro -15-Keto PGEi < 0.01% 
PGF1a < 0.01 % 
PFF2" < 0.01 % 
PGF3" < 0.01 % 
Thromboxane Bi < 0.01 % 
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The kit contains a 96 well microtiter plate. The wells are pre-coated with goat 
anti-mouse polyclonal antibody. The polyclonal antibody is produced as follow: PGE2 
hapten which is attached to a strong immunogen is injected into a recipient mouse to 
produce an antibody responsive to PG£i. This antibody serves as a haptenic antigen for 
injection into the goat. The antibodies produced by the goat are anti-mouse polyclonal 
antibody. 
Among other contents of the Kit is PGEi - acetylcholinesterase conjugate. 
Acetylcholinesterase is isolated from the electric organ of the electric eel, Electrophorus 
electricus. This stable enzyme is covalently attached to a molecule of the analyte (PGEi) 
and serves as a tracer in the test system. The enzyme is capable of high turnover for the 
hydrolysis of acetylthiocholine. Quantification of the tracer is accomplished by 
measuring its acetylcholinesterase activity with Ellman's Reagent provided in the kit. 
Ellman' s Reagent is made up of acetylthiocholine and 5, 5 '-dithio-bis-(2-nitroben-
zoic acid). Acetylcholinesterase hydrolizes the acetylthiocholine to produce thiocholine 
(Figure 3). The 5, 5'dithio-dis-(2-nitrobenzoic acid) will then nonenzymatically react 
with thiocholine to produce 5-thio-2-nitrobenzoic acid which has a strong absorbance at 
412 nm. 
The test is performed by adding all reactants (samples containing PG:Ei, PGEi 
tracer, and PGEi monoclonal antibody) to the goat anti-mouse coated wells. The assay 
is based on the competition between sample PG:Ei and a PGEi tracer for a limited amount 
of PGEi monoclonal antibody. Since the concentration of the PGEi tracer is constant, 
yet the concentration of sample PGEi is variable, the amount of PGEi tracer 
0 
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Figure 3. Reaction catalyzed by acetylcholinesterase (adapted from Cayman Chemical 
Company instruction handbook) 
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which binds to the PGEi monoclonal antibody is inversely proportional to the 
concentration of sample PG:Ei. 
The antibody-PGEi complex will attach to the attached goat anti-mouse antibody 
in the wells. The plate is washed to remove any unbound reagents. In the final step an 
appropriate substrate (Ellman's Reagent) is added to the wells. The enzyme hydrolyzes 
the substrate, forming a distinct yellow color whose intensity, determined 
spectrophotometrically, is proportional to the amount of PGEi tracer bound to the well. 
A schematic of this process is shown in Figure 4. 
Preassay Preparation 
The Enzyme Immunoassay Buffer and the wash buffer were made by dissolving 
the content of EIA and wash buffer packet (proprietary formulation) in 500 mL ultrapure 
water. Tween 20 at 0.25 mL was added to the wash buffer and mixed by swirling. Both 
buffers were stored at 4 °C until needed. PGEi tracer and PGEi monoclonal antibody 
were reconstituted with 6 mL EIA buffer and stored at 4 °C. 
A vial of PGEi standards was reconstituted with 1 mL EIA buff er. The 
concentration of this solution (the bulk standard) was 10 ng/mL. To prepare the 
standards for establishing an eight point standard curve, 8 test tubes were obtained and 
labeled #1 through #8. 900 µL of EIA buffer was added to tube #1 and 500 µL BIA 
buffer was added to tubes #2-8. 100 µL of the bulk standard (10 ng/mL) was transferred 
to tube #1 and mixed thoroughly. The standard was serially diluted as follows: 500 µL 
of solution from tube #1 was transferred into tube #2. After sufficient mixing, 500 µL 
solution from tube #2 was transferred to tube #3 and was mixed well. This process was 
)- Goat Anti-Mouse Polyclonal Antibody 
- Blocking Proteins 
llO PG~:AChE Conjugate (Tracer) 
:i- PGE2 Monoclonal Antibody 
o PGE
2 
1. Plates are provided 
pre-coated with goat 
anti-mouse antibody 
and blocked with a 
proprietary formulation 
of blocking proteins. 
3. Wash to remove all 
unbound reagents. 
2. Incubate with tracer, 
monoclonal antibody, 
and either standard or 
sample. 
4. Develop the well with 
Ellma.n's Reagent 
21 
Figure 4. Schematic of Enzyme Immunoassay (adapted from Cayman Chemical 
Company instruction handbook) 
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repeated for tubes #4-8. The product of this dilution represented standards numbered 1 
through 8; with concentration of 1000, 500, 250, 125, 62.5, 31.3, 15.6, and 7.8. 
Standards were stored at 4 °C and used within one hour of preparation. 
Plate Set Up 
Plate was prepared to contain two blanks (B), two non-specific binding wells 
(NSB), two maximum binding wells (B0), and an eight point standard curve, run in 
duplicate (Appendix C contains definition of key terms). Each sample was assayed in 
duplicate. We also included a 1 :2 dilution of each sample, set in duplicate, in the assay 
to confirm the samples appropriate purification. This is because a significant disparity 
between the apparent concentration of two different dilutions of the same sample would 
indicate interference. Plate format, and the location and contents of the wells is shown 
in Table 3. 
Perf ormin& the Assay 
Plate packet was opened immediately prior to use and wells were rinsed once with 
wash buffer. The unused strips were put back in the plate packet without rinsing and 
stored at 2-4 °C. 
The EIA buffer at 100 µL was added to non-specific binding (NSB) wells. The 
EIA buffer at 50 µL was added to maximum binding (B0) wells. The PGE.i standards (S1 
-S8) at 50 µL were added to the respective wells. Each sample and each 1 :2 diluted 
sample at 50 µL was added to the appropriate wells (see Test Plate Format; Table 3). 
The PGEi tracer at 50 µL was added to each well, except the total activity (TA) and the 
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Table 3. Test Plate Format showing the location and contents of wells 
1 2 3 4 5 6 7 
A B S1 S5 Ts (UND) Ts (1 :2) Tp (UND) Tp (1 :2) 
5 dpi 5 dpi 5 dpi 
5 dpi 
B B S1 S5 Ts (UND) Ts (1 :2) Tp (UND) Tp (1 :2) 
5 dpi 5 dpi 5 dpi 
5 dpi 
C NSB S2 S6 Ts (UND) Ts (1 :2) Tp (UND) Tp (1 :2) 
11 dpi 11 dpi 11 dpi 11 dpi 
D NSB S2 S6 Ts (UND) Ts (1 :2) Tp (UND) Tp (1 :2) 
11 dpi 11 dpi 11 dpi 11 dpi 
E B0 S3 S7 Ts (UND) Ts (1:2) Tp (UND) Tp (1:2) 
21 dpi 21 dpi 21 dpi 21 dpi 
F B0 S3 S7 Ts (UND) Ts (1:2) Tp (UND) Tp (1:2) 
21 dpi 21 dpi 21 dpi 21 dpi 
1:-:-:-:-:-:-:-:-:·:-:-:--:-: ·::::::::::::::::::::: 
G B0 S4 S8 Control Control 
1 
;;::: ii f }!!·. ! @.I f ··it i.i:' ' i Ct if.ii 
1:2 :.:;.::·: : ::: . .:::::.1.:.:·.::::.itii-:·i 
H TA S4 S8 Control Co~trol ,,, / i I 
1.2 "'"''">/• ••.•• :::::::: !:<:: 
Key: (B) Blank; (TA) Total Activity; (NSB) Non-Specific Binding; (B0) Maximum 
Binding; (Sl-S8) Standards 1-8; (Ts) Trichinella spiralis (Tp) Trichinella 
pseudospiralis; (UND) Undiluted sample; (1:2) 1:2 diluted sample. 
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blank (B) wells. The PGEi monoclonal antibody at 50 µL was added to each well except 
the total activity (TA), the non-specific binding (NSB), and the blank (B) wells. 
The plate was covered with plastic film and incubated for 18 hours at room 
temperature. After incubation was completed, a vial of Ellman's Reagent was 
reconstituted with 20 mL ultrapure water. The wells were emptied and rinsed five times 
with wash buffer, followed by addition of 200 µL Ellman' s Reagent to each well. In 
addition 5 µL of tracer was added to the TA well. The plate was covered with plastic 
film and rotated on an orbital shaker for 90 minutes. This process is referred to as 
development. Following development, the plate was read at 405 nm using a microplate 
autoreader model EL311 (Bio-Tek Instruments, Inc.; Winooski, VT). 
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RESULTS 
The absorbance readings, raw data, from the wells, are shown in Table 4. The 
results were calculated manually by averaging the absorbance readings from the NSB and 
B0 wells and then subtracting the NSB average from the B0 average. This resulted in the 
corrected B0 (corrected maximum binding). The % B/B0 (percent sample or standard 
bound/maximum bound) was calculated for the remaining wells by subtracting the 
average NSB absorbance from each sample and standard absorbance and dividing the 
value by the corrected B0• The result was then multiplied by 100 to obtain % B/Bo. The 
results of corrected B0 and % B/B0 for all standards and samples are presented in Table 
5. 
NOTE: The plate reader had subtracted the absorbance readings of the blank 
wells from the absorbance readings of the rest of the plate. 
Using Sigma Plot software, version 5.0, a standard curve was generated by plotting % 
B/B0 for standards S 1-S8 versus PGEi concentration in pg/mL (Figure 5). I determined 
the concentration of each sample by identifying the % B/B0 on the standard curve and 
reading the corresponding values on the x-axis. Since samples were assayed in duplicate, 
an average of the two absorbance readings was used to determine the PGEi 
concentration. 
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Table 4. Presentation of raw data; the Location of each well corresponds to that of plate 
format presented in Table 3. 
I 1 2 3 4 5 6 7 
A 0.000 0.034 0.217 0.118 0.181 0.072 0.148 
B 0.000 0.033 0.209 0.121 0.175 0.065 0.152 
c 0.005 0.057 0.246 0.125 0.194 0.062 0.146 
D 0.003 0.055 0.251 0.131 0.189 0.071 0.148 
E 0.309 0.101 0.294 0.168 0.209 0.051 0.114 
F 0.308 0.096 0.275 0.175 0.215 0.058 0.109 
G 0.309 0.156 0.306 0.118 0.245 ::::::: :::::::iiii[ii 1•···•·>•············· ............... ·.···/ 
H 0.998 0.158 0.302 0.121 0.249 w:::1:::1::1r1::1:::: i<lii!:i!i! 1:::::::i f !i !ii 
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Table 5. Corrected Maximum Binding, and % Sample and Standard Bound/Maximum 
Bound(% B/B0) 
Sample Corrected 8 0 % B/80 
Sl 0.03 0.029 9.84 9.51 
S2 0.053 0.051 17.38 16.72 
S3 0.097 0.092 31.80 30.16 
S4 0.152 0.154 49.84 50.49 
Standards 
SS 0.213 0.205 69.83 67.21 
S6 0.242 0.247 79.34 80.98 
S7 0.290 0.271 95.08 88.85 
SS 0.302 0.298 99.02 97.70 
5 dpi 0.114 0.117 37.37 38.36 
11 dpi 0.121 0.127 39.67 41.16 
21 dpi 0.164 0.171 53.77 56.07 
Trichinella spiralis 
5 dpi (1:2) 0.177 0.171 58.03 56.07 
11 dpi (1:2) 0.190 0.185 62.30 60.66 
21 dpi (1:2) 0.205 0.211 67.21 69.18 
5 dpi 0.068 0.061 22.30 20.00 
11 dpi 0.058 0.067 19.00 21.96 
21 dpi 0.047 0.054 15.41 17.70 
Trichinella 
pseudospiralis 5 dpi (1:2) 0.144 0.148 47.21 48.52 
11 dpi (1:2) 0.142 0.144 46.56 47.21 
21 dpi (1:2) 0.110 0.105 36.06 34.43 
Undiluted 0.102 0.097 33.44 31.80 
Control 
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Figure 5. Standard curve for PGEi using the Prostaglandin Bi monoclonal enzyme 
immunoassay kit. 
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The concentrations of PGEi in the plasma from the various groups of mice are 
summarized in Table 6. Because the samples were concentrated by a factor of 10 in 
purification process, the values obtained for PGEi concentration were divided by 10. As 
shown in Table 6, PGEi concentration was increased in mice infected with Trichinella 
pseudospiralis compared with uninfected mice. While there was a significant elevation 
of 21 dpi, samples collected 5 dpi and 11 dpi exhibited varying, but not significantly 
different levels of PG.Ei. The PG.Ei levels, on the other hand, were decreased in mice 
infected with Trichinella spiralis. Samples obtained at various time intervals showed 
various levels of PGEi. A comparison of PGEi levels in infected and uninfected animals 
is presented in Figure 6. The concentrations of samples diluted at 1 :2 were not 
determined. This was because a number of the % B/B0 values would fall out of the 
linear range of the standard curve due to the low PGEi concentration of the diluted 
samples. However, I estimated the concentration of some of the diluted samples whose 
% B/B0 were determinable on the standard curve (data not shown). These values, 
considering their dilution factor, were within 10 % of those of undiluted samples. This 
reassured that the purification process on the plasma had eliminated the possible 
interferences. 
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Table 6. PGEi concentration of known standards (shaded) and unknown various groups 
of mice (unshaded). 
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Figure 6. Comparison of PGE2 variation in the mouse infected with Trichinella spiralis 
versus Trichinella pseudospiralis at various intervals postinfection. Normal control 
values are included for comparison. PGE2 reported values are in pg/ml. 
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DISCUSSION 
Host protective immunity to the skeletal muscle dwelling larvae of the nematode 
Trichinella spiralis is mediated by an extensive cellular infiltration. Opposingly, the 
muscle stage infection of Trichinella pseudospiralis does not elicit an immune response 
that is characterized by elevated levels of inflammatory phagocytic cells. 
Inflammatory cells are recruited to the relevant site of inflammation via a number 
of mediators and enzymes. These cellular products are either released from granules and 
other cytoplasmic storages or are synthesized de novo from membrane phospholipids. 
The purpose of this study was to determine a change in concentration of PGEz 
in the mouse plasma as a possible correlation between these differences in host 
inflammatory response to infection with Trichinella spiralis versus Trichinella 
pseudospiralis. 
I approached my investigation by measuring circulatory PGEz levels in each one 
of the infections and then assumed a correlation between possible variations of these 
measurements and the host inflammatory response to each infection observed in previous 
studies. 
The results obtained in this study showed elevated levels of PGE:z in mice infected 
with Trichinella pseudospiralis compared with uninfected animals. Conversely, we 
observed a decreased PGE:z level in the host infected with Trichinella spiralis. 
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Therefore, I suggest an anti-inflammatory action for PGEi based on the assumption that 
the inhibition of neutrophil migration in response to Trichinella pseudospiralis infection 
is associated with the increase of PG:Ei level. The observed decreased level of PGEi in 
this study and its possible relation to the enhancement of cellular infiltration in infection 
with Trichinella spiralis is in accordance with our suggestion for anti-inflammatory role 
of PG:Ei. 
Prostaglandin Bi has been extensively studied in association with inflammation. 
This fatty acid has been regarded as proinflammatory mediator since it is a strong 
vasodilator and can act synergistically with other inflammatory mediators (Leal-Berumen 
et al., 1995). However, there are circumstances when PGEi may have an anti-
inflammatory role. For example, it has been reported that PGEi blocks a variety of 
responses to chemotactic peptides (O'Flaherty et al., 1979). 
Nonetheless, the literature in this field contains a number of conflicting 
observations. Several in vivo studies have shown that the neutrophil accumulation at 
local sites of inflammation is enhanced by PGEi (Issekutz, 1981; Issekutz and Movat, 
1982; Buckley et al., 1991). Additionally, Dong et al. in 1993 demonstrated that PGEi 
concentration in burned-infected rats enhanced neutrophil migration (Dong et al., 1993). 
On the other hand, Goetzl and Gorman in 1977 revealed that the PGEi exhibited 
negative chemokinetic activity and inhibited chemotactic migration of PMNs (Goetzl and 
Gorman, 1977). Furthermore, Raud and his co-workers in 1988 reported that PGEi 
reduced the number of emigrated leukocytes (Raud et al., 1988). The inhibitory action 
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of PGEi that I have theorized based on our observations is in accordance with the latter 
reports. 
After an extensive search of literature in attempt to understand the mechanism(s) 
underlying the immunosuppressive action of PGEi, I found three possible mechanisms 
by which the anti-inflammatory role of PGEi might be explained. 
One possible mechanism may be that the PGEi mediates its effect on neutrophil 
migration through cyclic- 3', 5'-adenosine monophosphate (cAMP). 
Bjornson et al. in 1992 demonstrated that intracellular cAMP is increased in 
PMNs following thermal injury in the guinea pig, and the elevation of intracellular 
cAMP had important effect on defective chemotaxis of the PMNs in response to 
chemoattractants (Bjornson et al., 1992). Furthermore, it was found that PGEi increased 
cAMP level in human mononuclear cells which in tum inhibited the mitogenesis of the 
cells (Goodwin and Webb, 1980). Also, Chouaib and his associates in 1985 
demonstrated that PGEi inhibits T lymphocyte activation and proliferation by increasing 
the intracellular concentration of cAMP. 
I propose that the following sequence of events may be responsible for the 
suppression of inflammatory response observed in mice infected with Trichinella 
pseudospiralis. 
When macrophages encounter inflammatory stimuli (Trichinella pseudospiralis 
antigens), they respond by releasing a number of products including PGEi (Humes et al., 
1977). This is accomplished by phagocytosis of the antigen which triggers the release 
of lysosomal phospholipases. The phospholipases hydrolyze phospholipids of cell 
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membranes and yield arachidonic acid. The production of PGEi is by enzyme activity 
of cyclooxygenase on produced arachidonic acid (Higgs and Vane, 1983). The PGEi 
synthesized and secreted by macrophages can then modulate the action of other 
immunocompetent cells, including neutrophils. Prostaglandin Bi activates the cAMP-
dependent intracellular signal transduction pathway in neutrophils by binding to the 
specific receptors on neutrophil plasma membrane (Alberts et al., 1989; Becker and 
Deamer, 1990). 
The neutrophil receptors activate a group of membrane-bound guanosine 
triphosphate-binding proteins, called G-proteins. When active, the G-proteins bind 
guanosine triphosphate (GTP) and activate the enzyme adenylate cyclase which catalyzes 
the reaction that converts adenosine triphosphate (ATP) to cAMP (Tizard, 1995). Thus, 
the intracellular cAMP level increases and activates cAMP-dependent protein Kinase A. 
This enzyme phosphorylates myosin light-chain kinase which in tum greatly reduces the 
affinity of the kinase for the calcium calmodulin complex (Becker and Deamer, 1990). 
The light-chain kinase catalyzes the process of myosin molecules aggregation into small 
dipolar filaments. The kinase itself is activated by Ca2+ - calmodulin complex (Barrett, 
1988). In this way PGEi inhibits migration of neutrophils because in these cells directed 
migration requires actin filaments (Alberts et al., 1989). 
In addition to the proposed sequence of event, the elevated cAMP may exhibit its 
effect through the suppression of chemokines. Strieter et al. in 1988 reported that an 
increase in cAMP interfered with endotoxin-induced transcription of the Tumor Necrosis 
Factor (TNF-a) gene. Tumor Necrosis Factor is known to dramatically increase the 
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binding of neutrophils to endothelium (Bouma et al., 1994). In vivo migration of 
neutrophils to sites of acute inflammation requires the adhesion and binding of these cells 
to vascular endothelial cells (Hallman et al., 1991). Therefore, elevated cAMP may 
inhibit the neutrophil migration into tissues by suppressing the production of TNF-a, the 
chemokine which mediates the neutrophil attachment to vascular endothelium. 
Regardless of its mode of action, increased cAMP appears to decrease neutrophil 
migration into tissues. 
The second possible mechanism for the inhibitory role of PGf:i on neutrophilic 
response is associated with corticosteroids. PGEi is known to increase steroidogenesis 
(Zurier et al., 1973). This effect of PGEi is well reviewed in literature (Flack et al., 
1969; Saruta and Kaplan, 1971). Corticosteroids decrease neutrophil adherence to 
vascular endothelium (margination) and reduce neutrophil emigration into inflamed 
tissues. Corticosteroids also depress abilities of neutrophils to phagocytise and respond 
to chemokinesis (Tizard, 1995). Thus, the anti-inflammatory action of PGEi in relation 
to its steroidogenesis activity appears to be based on inhibition of neutrophil atachment 
to vascular endothelial cells prior to migration surrounding tissues. 
The third proposed mechanism relates to the possible effect of PGEi on a 
neutrophil glycoprotein expression. Lewinsohn et al. in 1987 showed that MEL-14 
antigen, a neutrophil surface glycoprotein defined by the monoclonal antibody MEL-14, 
inhibits the capacity of neutrophils to migrate from the blood into sites of acute 
inflammation by blocking the interaction of neutrophils with endothelial cells. Therefore 
considering the capacity of PGEi to suppress neutrophil migration, it is reasonable to 
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My findings support the hypothesis that PGEi may be an inhibitor of the 
inflammatory process in Trichinella pseudospiralis , particularly acting on the migration 
of neutrophils. It is obvious, however, that before a definitive statement can be made 
with regard to the exact relationship between PGEi and neutrophil movement, it will be 
necessary to conduct additional studies to determine the precise mechanism(s) by which 
PGEi modulates this anti-inflammatory response. 
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APPENDIX A 
Sep-Pak C18 Cartridge Sample Preparation Strategy 
After placing the sample on the cartridge: 
A. Eliminate high polarity compounds by washing the sep-park cartridge with a polar 
solvent. The polar solvent should be chosen so that the compound(s) of interest 
is retained on the cartridge. 
B. Remove the compound(s) of interest by washing the sep-park cartridge with a less 
polar solvent. The cartridge eluent collected can now be brought to a known 
volume for final analysis. 
C. The non-polar compounds still remain on the cartridge. Additional compounds 
can be eluted with a non-polar solvent, or discarded along with the spent 
cartridge. 
NOTE: When using the sep-pak C18 cartridge with aqueous samples, it is 
necessary to pre-wet the cartridge with about 5 mL of a water-




Source of Ultrapure Water 
Water used to activate C18 cartridges and to prepare all EIA reagents and buffer was 
deionized and free of trace organic contaminants ("Ultra Pure"). Four types of filters 
were used in the water deionizer: 
a. Pre-filter Cartridge 
b. Two Ion-exchange (millipore) cartridges 
c. Activated charcoal (millipore) cartridge 
d. 0. 2 micron cross flow filter 
The water met the requirements of the College of America Pathology (CAP) and the 
National Committee for Clinical Laboratory Standards (NCCLS) for resistivity and 
minimal contamination. 
Sybron/Barnstead Deionized water system: 
Filter: Barnstead/Thermo I yne 
Catalog# D0809: Ultrapure DI cartridge 
Lot #31 I Expiration Date: 12/95 
Rosin description: Di Vinyl Benzene Styrene manufactured by Rohm and Haaf. 
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APPENDIXC 
Definition of Key Terms 
Blank: Background absorbance caused by Ellman' s Reagent. Even freshly 
prepared Ellman's Reagent has some measurable absorbance, approximately 0.2 
Absorbance Units (A.U.). The blank absorbance should be subtracted from the 
absorbance readings of all the other wells. 
Total Activity: Total enzymatic activity of the acetylcholinesterase-linked tracer. 
This is analogous to the specific activity of a radioactive tracer. 
NSB (Non-Specific Binding): Non-immunological binding of the tracer to the 
well. Even in the absence of specific antibody a very small amount of tracer still binds 
to the well; the NSB is a measure of this low binding. 
B0 (Maximum Binding): Maximum amount of the tracer that the antibody can 
bind in the absence of free anal yte. 
B/B0 (Bound/Maximum Bound): Ratio of the absorbance of a sample or standard 
well to that of the maximum binding (Bo) well. 
Standard Curve: A plot of the B/Bo values versus concentration for a series of 
wells containing various known amounts of analyte. 
